LINDA SOQUI: Open Payments
NPI 1639833213 · MARTINSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 32 payments from 15 companies in 2025. Trend: 2023 $928 · 2024 $1,001 · 2025 $617
Food & beverage: $617
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $83 |
| Novo Nordisk Inc | 3 | $77 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Lilly USA, LLC | 4 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $55 |
| PFIZER INC. | 3 | $53 |
| ABIOMED | 2 | $41 |
| Boston Scientific Corporation | 1 | $39 |
| Amgen Inc. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
Products named: MOUNJARO, BOTOX, LEQVIO, Wegovy, FARXIGA, WATCHMAN FLX, REPATHA, Rybelsus.
Industry payments across VA — which companies pay providers there.
